RankAlpha logo
Back to Rankings

OKUR

OnKure TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
OKUR vs peer average
72/100
OKUR vs. peer average (B vs. C)
Grade spread
B 4 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

HUMA is the first available peer comparator.

Humacyte is only a loose small-cap development-stage biotech comparator from the packet. It is useful mainly for event-risk and financing sensitivity, not for direct PI3Kα pipeline benchmarking.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerHUMAHumacyte
OKUR
OnKure Therapeutics
HUMA
Humacyte
Grade
B
F
Momentum
59
13
Value
58
41
Sentiment
47
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs HUMA

OKUR / HUMA
Grade Position
Above peers
OKUR vs. peer average (B vs. C)
72/100
Momentum
59
OKUR
Value
58
OKUR
Sentiment
47
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OKUR
1
HUMA
HUMA
F
20/100
+3
2
LENZ
LENZ
B
80/100
Even
3
ADAG
Adagene Inc ADR
B
80/100
Even
4
ANTX
AN2 Therapeutics Inc Common
B
80/100
Even
5
ADCT
ADC Therapeutics Ltd Common
C
60/100
+1
HUMA is the first peer returned for this comparison set.